Chloroquine Phosphate Powder
NDC Package 68022-7057-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Chloroquine Phosphate powders is chloroquine is used to prevent or treat malaria caused by mosquito bites. This formulation utilizes a powder delivery system. Marketed by Cohance Lifesciences Limited, this product is identified by NDC 68022-7057.

Identification & Billing

NDC Package Code
68022-7057-2
Package Description
25 kg in 1 DRUM
Product Code
68022-7057
11-Digit Billing Format
68022705702

Clinical Specifications

Proprietary Name
Chloroquine Phosphate
Non-Proprietary Name
Chloroquine Phosphate
Substance Name
Chloroquine Phosphate
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
CHLOROQUINE PHOSPHATE 1 kg/kg
Usage Information
Chloroquine is used to prevent or treat malaria caused by mosquito bites. Chloroquine belongs to a class of drugs known as antimalarials. The United States Centers for Disease Control provide updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. Chloroquine is also used to treat infection caused by a different type of parasite (ameba). Chloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits.

Regulatory & Marketing

Labeler Name
Cohance Lifesciences Limited
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
Start Marketing Date
12-26-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68022-7057). Click a package code to view its specific billing and regulatory data.

68022-7057-3
10 kg in 1 DRUM
68022-7057-8
1 kg in 1 DRUM
68022-7057-9
.001 kg in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68022-7057-2 identifies a specific commercial package of 25 kg in 1 drum of Chloroquine Phosphate (UNFINISHED drug), a bulk ingredient labeled by Cohance Lifesciences Limited. This powder is formulated for use and contains chloroquine phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cohance Lifesciences Limited on December 26, 2018. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Chloroquine is used to prevent or treat malaria caused by mosquito bites. Chloroquine belongs to a class of drugs known as antimalarials. The United States Centers for Disease Control provide updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. Chloroquine is also used to treat infection caused by a different type of parasite (ameba). Chloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits.

How is this Cohance Lifesciences Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68022705702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68022-7057-2
11-Digit CMS (5-4-2)
68022-7057-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.